As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Shaping the Future of Healthcare Beyond Hospital Walls
At the 49th IHF World Hospital Congress, IHH Healthcare North Asia shared how connected care networks, digital innovation and preventive health can reshape care delivery.
Gleneagles BGS Champions Spine Health and Recovery
Gleneagles BGS Hospital brought together patients, clinicians and spine health advocates to celebrate life after spinal surgery while raising awareness of early diagnosis and timely intervention.
Pantai KL Brings Cancer Care Closer to More Communities
Pantai Hospital Kuala Lumpur has strengthened its oncology services with the soft launch of the Pantai Oncology Daycare Centre in Cheras, bringing cancer treatment closer to patients and families.
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
